Immediate Impact
16 from Science/Nature 63 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
2025 Standout
Works of Heather Vezina being referenced
Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors
2017
Antibody–Drug Conjugates as Cancer Therapeutics: Past, Present, and Future
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heather Vezina | 461 | 222 | 107 | 218 | 25 | 863 | |
| Qiwen Fang | 362 | 339 | 31 | 176 | 31 | 1.1k | |
| Sharon Lu | 349 | 190 | 30 | 167 | 48 | 849 | |
| N. George Liomba | 221 | 173 | 29 | 194 | 24 | 1.2k | |
| Laura Farrelly | 183 | 207 | 74 | 299 | 44 | 832 | |
| J.A. Gastaut | 283 | 232 | 23 | 244 | 38 | 1.1k | |
| Lucy Rowell | 271 | 80 | 109 | 122 | 31 | 1.1k | |
| Siobhán O’Connor | 205 | 238 | 49 | 82 | 49 | 1.0k | |
| Brian P. Mulhall | 255 | 431 | 50 | 245 | 40 | 1.1k | |
| Colleen Pelser | 330 | 108 | 20 | 113 | 16 | 801 | |
| Jean-Marie Dangou | 447 | 271 | 79 | 42 | 41 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...